A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 31/445 (2006.01) A61K 31/451 (2006.01) A61K 31/453 (2006.01)
Patent
CA 2299400
Dyskinesias in humans are treated by administering a therapeutically effective dose of an NR1A/2B site-selective NMDA receptor antagonist compound to a human suffering therefrom.
On traite, au titre de cette invention, des dyskinésies chez l'homme par administration d'une dose, efficace du point de vue thérapeutique, d'un composé d'un antagoniste du récepteur du N-méthyl-D-aspartate (NMDA) sélectif du site NR1A/2B.
Macrae & Co.
Warner-Lambert Company
LandOfFree
Method for treating disease-related or drug-induced dyskinesias does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating disease-related or drug-induced dyskinesias, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating disease-related or drug-induced dyskinesias will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1883090